ZENAS BIOPHARMA INC

Ticker: ZBIO CUSIP: 98937L105 Class: Common Stock

Fairmount Funds Management LLC's Holding History (CIK: 0001802528)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 2,209,025 Value ($000) $80,210 Avg Close $32.89 Range $18.33 - $44.60

Q3 2025

Shares 1,892,806 Value ($000) $42,020 Avg Close $16.28 Range $8.91 - $22.45

Q2 2025

Shares 1,892,806 Value ($000) $18,341 Avg Close $9.74 Range $6.11 - $12.56

Q1 2025

Shares 1,892,806 Value ($000) $14,953 Avg Close $7.83 Range $5.83 - $10.95

Q4 2024

Shares 1,892,806 Value ($000) $15,502 Avg Close $15.60 Range $7.79 - $26.25

Q3 2024

Shares 1,892,806 Value ($000) $32,026 Avg Close $17.98 Range $16.35 - $20.50

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	2,209,025	$80,210	$32.89	$18.33 - $44.60
Q3 2025	1,892,806	$42,020	$16.28	$8.91 - $22.45
Q2 2025	1,892,806	$18,341	$9.74	$6.11 - $12.56
Q1 2025	1,892,806	$14,953	$7.83	$5.83 - $10.95
Q4 2024	1,892,806	$15,502	$15.60	$7.79 - $26.25
Q3 2024	1,892,806	$32,026	$17.98	$16.35 - $20.50